1. Home
  2. BDSX vs JOF Comparison

BDSX vs JOF Comparison

Compare BDSX & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • JOF
  • Stock Information
  • Founded
  • BDSX 2005
  • JOF 1990
  • Country
  • BDSX United States
  • JOF Japan
  • Employees
  • BDSX N/A
  • JOF N/A
  • Industry
  • BDSX Precision Instruments
  • JOF Trusts Except Educational Religious and Charitable
  • Sector
  • BDSX Health Care
  • JOF Finance
  • Exchange
  • BDSX Nasdaq
  • JOF Nasdaq
  • Market Cap
  • BDSX 245.3M
  • JOF 227.5M
  • IPO Year
  • BDSX 2020
  • JOF N/A
  • Fundamental
  • Price
  • BDSX $1.60
  • JOF $7.79
  • Analyst Decision
  • BDSX Strong Buy
  • JOF
  • Analyst Count
  • BDSX 4
  • JOF 0
  • Target Price
  • BDSX $3.08
  • JOF N/A
  • AVG Volume (30 Days)
  • BDSX 118.2K
  • JOF 43.9K
  • Earning Date
  • BDSX 11-01-2024
  • JOF 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • JOF 3.33%
  • EPS Growth
  • BDSX N/A
  • JOF N/A
  • EPS
  • BDSX N/A
  • JOF N/A
  • Revenue
  • BDSX $60,902,000.00
  • JOF N/A
  • Revenue This Year
  • BDSX $48.06
  • JOF N/A
  • Revenue Next Year
  • BDSX $29.97
  • JOF N/A
  • P/E Ratio
  • BDSX N/A
  • JOF N/A
  • Revenue Growth
  • BDSX 46.25
  • JOF N/A
  • 52 Week Low
  • BDSX $1.15
  • JOF $6.64
  • 52 Week High
  • BDSX $2.21
  • JOF $8.04
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 39.90
  • JOF 36.07
  • Support Level
  • BDSX $1.59
  • JOF $7.94
  • Resistance Level
  • BDSX $1.68
  • JOF $8.06
  • Average True Range (ATR)
  • BDSX 0.06
  • JOF 0.12
  • MACD
  • BDSX -0.01
  • JOF -0.04
  • Stochastic Oscillator
  • BDSX 20.51
  • JOF 0.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About JOF Japan Smaller Capitalization Fund Inc

Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.

Share on Social Networks: